Health Bureau renews drug regulation agreement

The government will also establish a clinical trial facility in Hetao this year.

The Health Bureau and the National Medical Products Administration (NMPA) renewed the cooperation agreements on the Regulation of Drugs and the Construction, Research, & Management of Chinese Medicines Herbarium.

This follows the government’s “primary evaluation” approach to enhance the approval and registration of drugs and the establishment of an internationally recognised regulatory authority for drugs and medical devices announced at the 2023 Policy Address.

The government will also establish the Greater Bay Area International Clinical Trial Institute (GBAICT) in Hetao this year to provide a one-stop clinical trial support services in Hong Kong to transform the city into a leading clinical trial hub in Asia.

In addition, the Government Chinese Medicines Testing Institute launched the Digital Herbarium for Chinese Medicines website with information on over 220 types of commonly used Chinese materia medica.

Follow the link for more news on

Hong Kong Government

Also Read

Gov't opens GBA International Clinical Trial Institute in Shenzhen Park

Hospital Authority and ZOC-SYSU partner to enhance ophthalmology services

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit